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Available online 25 January 2017Foetal midbrain progenitors have been shown to survive, give rise to different classes of dopamine neurons and
integrate into the host brain alleviating Parkinsonian symptoms following transplantation in patients and animal
models of the disease. Dopamine neuron subpopulations in the midbrain, namely A9 and A10, can be identiﬁed
anatomically based on cell morphology and ascending axonal projections. G protein-gated inwardly rectifying
potassium channel Girk2 and the calcium binding protein Calbindin are the two best available histochemical
markers currently used to label (with some overlap) A9- and A10-like dopamine neuron subtypes, respectively,
in tyrosine hydroxylase expressing neurons both in the midbrain and grafts. Both classes of dopamine neurons
survive in grafts in the striatum and extend axonal projections to their normal dorsal and ventral striatal targets
depending on phenotype. Nevertheless, grafts transplanted into the dorsal striatum, which is an A9 input nucle-
us, are enriched for dopamine neurons that express Girk2. It remains to be elucidated whether different trans-
plantation sites favour the differential survival and/or development of concordant dopamine neuron subtypes
within the grafts. Here we used rat foetal midbrain progenitors at two developmental stages corresponding to
a peak in either A9 or A10 neurogenesis and examined their commitment to respective dopaminergic pheno-
types by grafting cells into different forebrain regions that contain targets of either nigral A9 dopamine innerva-
tion (dorsal striatum), ventral tegmental area A10 dopamine innervation (nucleus accumbens and prefrontal
cortex), or only sparse dopamine but rich noradrenaline innervation (hippocampus). We demonstrate that
young (embryonic day, E12), but not older (E14), mesencephalic tissue and the transplant environment inﬂu-
ence survival and functional integration of speciﬁc subtypes of dopamine neurons into the host brain. We also
show that irrespective of donor age A9-like, Girk2-expressing neurons are more responsive to environmental
cues in adopting a dopaminergic phenotype during differentiation post-grafting. These novel ﬁndings suggest
that dopamine progenitors use targets of A9/A10 innervation in the transplantation site to complete maturation
and the efﬁcacy of foetal cell replacement therapy in patients may be improved by deriving midbrain tissue at
earlier developmental stages than in current practice.
© 2017 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license (http://
creativecommons.org/licenses/by/4.0/).Keywords:
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Girk21. Introduction
Parkinson's disease (PD) is a progressive neurodegenerative disor-
der characterisedpathologically by a substantial loss ofmelaniseddopa-
mine neurons in the substantia nigra pars compacta (SNpc) and a
subsequent failure to supply dopamine to the putamen, which results
in impairedmotor, cognitive and neuropsychiatric functions in patients.
There is no therapy available to cure PD and current pharmacological
treatments, such as levodopa, only address the symptoms by restoringealth Research Institute, School
aindy Road, Cardiff, Wales CF24
Research Institute, School of
indy Road, Cardiff, Wales CF24
. This is an open access article underdopamine transmission in the striatum, alleviating some motor deﬁcits
but often having little effect, or even impairing, cognitive functions
(Hernandez et al., 2014; Obeso et al., 2011; Schneider et al., 2013). In
contrast, a series of proof-of-principle clinical trials demonstrated that
human foetal ventral mesencephalic (VM) dopamine progenitors, ec-
topically transplanted into the putamen and in some cases also into ei-
ther the caudate nucleus or the SNpc, resulted in signiﬁcant long-term
clinical improvement of motor function in patients and in several
cases there was no further need for levodopa treatment (Freed et al.,
1992; Hagell et al., 1999; Kefalopoulou et al., 2014; Lindvall et al.,
1992; Lopez-Lozano et al., 1997; Mendez et al., 2002, 2005, 2008;
Wenning et al., 1997). We have recently demonstrated that human
VM transplants are also capable of ameliorating non-motor dysfunc-
tions in a rat model of PD (Lelos et al., 2016).
The subtypes of dopamine neurons within embryonic VM grafts
have been the focus of many studies. Based on anatomical morphologythe CC BY license (http://creativecommons.org/licenses/by/4.0/).
Table 1
Group allocation for transplantation.
Animals were distributed in 8 balanced groups based on the number of amphetamine-in-
duced net ipsilateral rotations following 6-OHDA lesion. Data are presented as group
means±SEM, (number of animals per group [surviving primary grafts, dSTRorN.Acc/sur-
viving secondary grafts, PFC or HPC]).
Donor age
Transplantation site
dSTR
PFC
N.Acc
PFC
dSTR
HPC
N.Acc
HPC
E12
1242 ± 273
(n = 5 [5/5])
1268 ± 260
(n = 4 [4/3])
1307 ± 500
(n = 4 [4/4])
1245 ± 264
(n = 5 [5/5])
E14
1190 ± 168
(n = 5 [6/5])
1388 ± 380
(n = 4 [3/2])
1298 ± 428
(n = 4 [4/4])
1245 ± 227
(n = 5 [5/4])
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the brain three are present in the developing mammalian midbrain –
A9 neurons of the SNpc, A10 neurons of the ventral tegmental area
(VTA), and A8 neurons of the retrorubral ﬁeld (Dahlstrom and Fuxe,
1964). Anatomically the key sites are the SNpc andVTA collectively con-
taining≈90% of all dopamine neurons in the ratmidbrain (German and
Manaye, 1993; Nair-Roberts et al., 2008). In a very simpliﬁedmodel, A9
neurons and their ascending axonal projections to the dorsal striatum
(dSTR) in rodents (caudate nucleus and putamen in primates) comprise
the nigrostriatal pathway while A10 neurons in the mesocorticolimbic
pathway extend their axons primarily to the ventral striatum, also
known as nucleus accumbens (N.Acc) and cortical areas, but also to
the olfactory tubercle, septum and amygdala (reviewed in Björklund
and Dunnett, 2007).
Subsequently, A9 and A10 neurons in themidbrain can be identiﬁed
based on cell morphology and expression proﬁles. Tyrosine hydroxy-
lase-immunoreactive (TH-ir) A9 neurons located in the ventral tier of
the SNpc aswell as the ventrolateral region of the VTA are large and an-
gular in shape andmost co-express G protein-gated inwardly rectifying
potassium channel 2 (Girk2), while TH-ir A10 neurons located in the
VTA and dorsal tier of the SNpc are smaller and round in shape and
mostly co-express the calcium binding protein Calbindin (Reyes et al.,
2012; Thompson et al., 2005). However, authors also reported that
strong levels of Girk2 protein can be detected in up to 5–25% of
Calbindin-ir/TH-ir neurons in the dorsal tier of the SNpc in mice and
humans. Nevertheless, several studies have demonstrated that these
distinctivemorphological features of the two dopamine neuron popula-
tions are retained after transplantation of embryonic VM and Girk2 and
Calbindin currently are best available surrogate markers that can be
used to deﬁne A9- and A10-like neurons once their positional criteria
are lost within grafts (Bye et al., 2012; Grealish et al., 2010; Mendez et
al., 2005; Thompson et al., 2005).
Increasing lines of evidence indicate that the restoration of function
by dopamine grafts is mainly due to the presence of A9-like neurons
(Grealish et al., 2010; Kuan et al., 2007). Although both subpopulations
of dopamine neurons are present in VM grafts in the dSTR, these grafts
are enriched for the A9-like neurons (Bye et al., 2012; Somaa et al.,
2015). The use of younger donor tissue and presence of meningeal
cells overlying the VM in graft preparation have already been identiﬁed
among the factors that favour the survival of A9-like neuron population
in grafts in dSTR and result in a more effective cell replacement therapy
in animalmodels of PD (Bye et al., 2012; Somaa et al., 2015; Torres et al.,
2008, 2007). We set out to determine whether other variables, such as
thehost environment external to the graft,mayhave inﬂuenced this im-
proved yield of functionally important A9-like neurons in transplants.
In particular, we questionedwhether targets of A9 innervation in the
dSTRmight have contributed to these effects. To this extent, we investi-
gated the commitment of dopamine neuron progenitors to the A9- and
A10-like fates by grafting younger, embryonic day 12 (E12), and con-
ventional age (E14) rat VM tissue into cerebral regions containing tar-
gets of either A9, A10 or noradrenaline innervation. We examined
whether different transplantation sites favour the differential survival
and/or development of concordant dopamine neuron subtypes within
the grafts. We believe this to be the ﬁrst systematic comparison of
A9-/A10-like cell populations in rat VM grafts transplanted at different
developmental stages into various environments in the context of PD.
2. Methods
2.1. Subjects
Sprague Dawley rats (Charles River, UK) were housed under stan-
dard conditions on a 14 h:10 h light/dark cycle with ad libitum access
to food andwater. All experiments were conducted under UKHomeOf-
ﬁce personal and project licences in accordance with the requirements
of the UK Animals (Scientiﬁc Procedures) Act 1986 and with theapproval of the local Cardiff University Ethics Review Committee.
Every effort was made to minimise the number of animals used and
their suffering.
2.2. Experimental design
To test our hypothesis, female rats were unilaterally lesioned with
the selective catecholamine neurotoxin 6-hydroxydopamine (6-
OHDA) into the nigrostriatal pathway and the lesions conﬁrmed with
amphetamine-induced rotations at 4 weeks post-lesion. Prior to trans-
plantation, rats were separated into 8 balanced groups based on rota-
tion performance [see Table 1; Group, F(7,28) = 0.03, n.s.]. All
transplants were made on the dopamine-depleted side of the brain. To
reduce the number of animals used in the experiment each animal re-
ceived 2 grafts implanted into widely separated sites in the denervated
hemisphere, with the ﬁrst transplant into either dSTR or N.Acc and the
second transplant into either prefrontal cortex (PFC) or hippocampus
(HPC). Efﬁcacy of the grafts was conﬁrmedwith amphetamine-induced
rotation tests at 4 and 6 weeks post-graft. Following the ﬁnal rotation
test animals were perfused and brain tissue taken for histological
analysis.
2.3. Medial forebrain bundle lesions
All surgeries were performed in a Kopf stereotaxic frame where an-
aesthesia was maintained at 2–3% Isoﬂurane (AbbVie Ltd., Maidenhead,
UK) in a 2:1 mixture of oxygen and nitrous oxide. For the unilateral
nigrostriatal lesion, rats received an intra-cerebral injection of 6-OHDA
neurotoxin into the right medial forebrain bundle following a recently
reﬁned protocol (Torres et al., 2011). Each animal was injected with
12 μg (free-base) of 6-OHDAhydrobromide (Sigma-Aldrich, Gillingham,
UK) in 3 μl of 0.025% ascorbate saline at the following stereotaxic coor-
dinates:−4.0mmcaudal from bregma (AP);−1.3mm lateral from the
midline (ML);−7.0 mm deep from dura (DV).
2.4. Procurement of embryonic ventral mesencephalic cells
Pregnant dams were bred in-house following a previously
established protocol (Weyrauch et al., 2009). Brieﬂy, females in oestrus
were established by the vaginal lavage method on the morning of
breeding day. Eligible females were paired with a male at 1:1 ratio in
the male's home cage for a maximum of 3 h, typically between
10:30 a.m. and 1:30 p.m. Females then returned to their home cages
and the day of mating was recorded as E0. At 10 a.m. on the morning
of E12, rats were lightly anaesthetised in an induction chamber with
2–3% Isoﬂurane in oxygen and the pregnancy was conﬁrmed if palpa-
tion of the abdomen revealed several swellings in the uterine horns.
Embryos were harvested straight away if the desired embryonic age
was E12, alternatively pregnant dams returned to their home cages
until E14. The shortmating-period protocol used here produced embry-
os with a crown-rump length (CRL) of 6.1 ± 0.3 mm at E12 and 11.2 ±
0.4 mm at E14 (CRL reported as mean ± standard deviation).
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dissected from each embryo according to a standard protocol (Dunnett
and Björklund, 1992). VMs from all donors in the same litter were
pooled together and quasi-singe cell suspensionswere prepared as pre-
viously described (Torres et al., 2007). The viability for each sample was
determined to be N95% using Trypan Blue exclusion criteria. For trans-
plantation, the VM cells were re-suspended in a sufﬁcient volume of
Dulbecco's minimum Eagle Medium F-12 (Gibco, Paisley, UK) contain-
ing 0.05% DNAse (deoxyribonuclease I from bovine pancreas, Sigma-Al-
drich) to obtain the required concentration of 1/2 VMper 2 μl and stored
on ice during surgery.
2.5. Transplantation
Six weeks post-lesion, each animal was transplanted with the num-
ber of cells equivalent to 1/2 VM, rather than with a ﬁxed number of
cells, to allow a comparison to bemade between grafts of similar poten-
tial at the different donor ages. Thus, each rat received grafts into 2 des-
ignated sites, each graft containing approximately 55,000 cells in E12
groupor 250,000 cells in E14 group. Overall, a total of 9 animals received
grafts of each donor age transplanted into each cerebral target. Stereo-
taxic co-ordinates were as follows: dSTR AP: +0.6 mm, ML:
−3.0 mm, DV: −5.0 & −4.5 mm; N.Acc AP: +1.6 mm, ML:
−1.5 mm, DV: −7.5 & −7 mm; PFC AP: +4.7 mm, ML: −2.0 mm,
DV:−1.9 &−1.4 mm; HPC AP:−5.2 mm, ML:−5.2 mm, DV:−5.4
&−4.9 mm (Paxinos and Watson, 2003). Cells were transplanted in a
single track at 2 depths 0.5 mm apart. The cell suspension was injected
into thebrain at a rate of 1 μl/min over 2min using the same set up as for
the 6-OHDA lesion surgery. After the ﬁrst minute, the cannula was
raised 0.5 mm and the second half of cells was injected at the new
depth. The cannula was left in place for 3 min after the injection before
being withdrawn to prevent drawback of the cells up the needle track.
2.6. Behavioural testing
The extent of dopamine depletion in the striatum was evaluated
4 weeks post-lesion based on the drug-induced rotational behaviour.
Amphetamine (Methamphetamine hydrochloride, Sigma-Aldrich) was
dissolved in sterile saline at 2.5 mg/ml and administered via i.p. injec-
tion at a dose of 1 ml/kg, immediately prior to testing. The animals
were placed in 30 cm diameter round bottomed bowls housed in
50 cmhigh perspex cylinders and harnessed to an automated rotometer
system (Rotomax System, AccuScan Instruments Inc., Columbus, USA)
following a previously established protocol (Ungerstedt and
Arbuthnott, 1970). Grafted rats were tested 4 and 6 weeks post-trans-
plantation using the same method. Drug-induced rotation tests were
performed blind to the treatment of the animals. The collected data
are reported as the net number of rotations (ipsilateralminus contralat-
eral) over the full 90 min session.
2.7. Perfusion
Six weeks post-graft, rats were terminally anaesthetised with an
overdose of sodium pentobarbital (Euthatal, Merial, UK) and
transcardially perfused with 0.1 M phosphate buffered saline (PBS)
followed by 1.5% w/v paraformaldehyde (Fisher Scientiﬁc, Loughbor-
ough, UK) in 0.1 M PBS. The brains were post-ﬁxed in the same ﬁxative
solution overnight before being transferred into a solution of 25% su-
crose in PBS. After equilibration in the sucrose solution, 40 μm thick cor-
onal sections through the brainwere cut on a Leica freezing stage sledge
microtome and collected in 1:6 series.
2.8. Immunohistochemistry
All bright-ﬁeld and ﬂuorescent immunohistochemistry (IHC) was
performed on free ﬂoating sections on an automated shaker. The tissuewas ﬁrst incubated for 1 h in a blocking solution of 3% normal horse
serum (NHS, Gibco) before being bathed in primary antibody with 1%
NHS overnight at room temperature. The next day, the sectionswere in-
cubated in secondary antibody (1:200) solution with 1% NHS for 3 h,
washed, and then immersed in Vectastain Elite ABC (Vector Laborato-
ries Ltd., Peterborough, UK) solution for 2 h prior to being stained
with DAB (diaminobenzidine tetrahydrochloride hydrate, Sigma-Al-
drich). The primary antibodies and dilution factors used in either
bright-ﬁeld or ﬂuorescent IHC were as follows: mouse anti-NeuN
(1:1000; Millipore, Feltham, UK), rabbit anti-TH (1:2000; Millipore),
mouse anti-TH (1:1000; Millipore), rabbit anti-Girk2 (1:250; Alomone
Labs, Jerusalem, Israel), andmouse anti-Calbindin (1:10,000; Sigma-Al-
drich). All Alexa ﬂuorescent secondary antibodies were used at 1:200
dilution.
2.9. Quantiﬁcation and microscopy
All quantiﬁcations of cell populations in the grafts were performed
blind to the experimental condition. Neuron quantiﬁcation in the grafts
fromNeuN stained sectionswas carried out on an automated stereology
microscope (Olympus BX50) at ×100magniﬁcation using image analy-
sis C.A.S.T. – grid software version 1.6 (Olympus, Ballerup, Denmark).
The area of the graft was outlined by the user and the software set up
randomised statistical sampling within the deﬁned area so that at
150–200 cells per animal were counted from at least 200 sampling
ﬁelds. Sampling parameters, i.e. area of the sampling frame (285 μm2)
and step size between the samples, were held constant for all animals
in each experiment. Total cell counts in the grafts for each staining
were estimated using the Abercrombie correction formula
(Abercrombie, 1946). To assess the extent of 6-OHDA lesions, numbers
of TH-ir cells were counted at ×10 magniﬁcation on the side ipsilateral
and contralateral to the lesion in onemidbrain section at the level of the
medial terminal nucleus of the accessory nucleus of the optic tract as an
anatomical landmark to distinguish cells in the VTA and SNpc (Dowd
and Dunnett, 2004).
To quantify cells labelledwith ﬂuorochromes, pictures of all sections
containing the graft were taken on a Zeiss Image Z2 microscope
equipped with the imaging system ApoTome (Oberkochen, Germany)
to generate deblurred optical sections of ﬂuorescence samples at ×10
magniﬁcation and single- and double-labelled cells were counted in
Adobe Photoshop CS5 software (Adobe Systems Inc., California, USA).
Using a grid generated in Photoshop as a reference, constant-size sam-
pling ﬁeld was selected from the widest area of the graft and the distri-
bution of Girk2-ir/TH-ir and Calbindin-ir/TH-ir neurons within the graft
was analysed by counting cells in the ﬁelds sampled from either the pe-
riphery (25% width of the graft from each side) or the centre (50%) of
the graft and grouping them accordingly for statistical analysis.
2.10. Statistical analysis
All data are expressed as group mean ± standard error of the mean
(SEM). Statistical analyses were performed in SPSS Statistics 23 (IBM
Corp., Armonk, USA). A general linear model (GLM) univariate function
was used to perform two- and higher factor analyses of variance
(ANOVAs) to analyse data from IHC staining. A four-way ANOVA with
repeated measures was used to analyse behavioural data from drug-in-
duced rotation tests. This analysis was performed orthogonally, treating
grafts in the dSTR or N.Acc as the primary graft and grafts in the PFC or
HPC as the secondary graft, to investigate whether PFC or HPC sub-
groups differed in either dSTR or N.Acc groups. Bonferroni correction
for multiple comparisons was used to reveal signiﬁcant differences be-
tween individual groups and results were considered to be signiﬁcant
if p b 0.05 (*), with higher levels of signiﬁcance (**p b 0.01,
***p b 0.001) also indicated where appropriate.
One grafted rat was transferred from E14 N.Acc group to E14 dSTR
group for all analyses after examination of TH-stained brain sections
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Furthermore, 3 of 18 animals in the PFC and 1 of 18 in the HPC groups
were missing grafts. This was most likely because cells were injected
into either a subdural or a sub-ventricular space as no trace of cells
was found in the target or adjacent brain regions. The resulting numbers
of grafts in each group used in further analyseswere as follows: dSTR– 9
E12 and 10 E14 grafts, N.Acc – 9 E12 and 8 E14 grafts, PFC – 8 E12 and 7
E14 grafts, HPC – 9 E12 and 8 E14 grafts.
3. Results
3.1. Functionality of the grafts
Rotational asymmetry in response to the indirect dopamine agonist,
amphetamine, was assessed at 4 weeks post-lesion and at 4 and
6 weeks post-graft. Post-lesion, all animals exhibited a rotational bias
toward the lesioned side, a classic behavioural deﬁcit induced by the
6-OHDA lesion to the nigrostriatal pathway (see Fig. 1). Grafts in the
dSTR and N.Acc produced signiﬁcantly different drug-induced rotation-
al behaviours in animals [Primary graft, F(1,28) = 55.57, p b 0.001]. All
rats, which had received grafts into the dSTR, showed a signiﬁcant be-
havioural recovery [Fig. 1A; Lesion vs dSTR at 4 and 6 week., both
p b 0.001] and some now rotated contralaterally to the lesioned side, a
classic ‘overcompensation’ response (Dunnett et al., 1981), while grafts
in the N.Acc exacerbated the rotational bias toward the lesioned side
[Fig. 1B; Lesion vs N.Acc at 4 and 6 week., both p b 0.05]. Grafts in either
the PFC or HPC did not interfere with drug-induced rotational response
provided by grafts in either dSTR or N.Acc [secondary graft, main effect,
F(1,28)= 1.31, n.s. and no signiﬁcant interactions]. Therefore, behaviour-
al data presented in Fig. 1 are collapsed across the secondary graft factor.
Rotational behaviour between the E12 andE14 groupswas very sim-
ilar in the dSTR group. In both donor age groups, grafts in the dSTR in-
duced an equally high signiﬁcant behavioural recovery [Fig. 1A; Lesion
vs E12 and E14 dSTR at 4 and 6 week., all p b 0.001]. On the other
hand, post-graft rotational behaviour in theN.Acc graft animals was sig-
niﬁcantly different between the two donor age groups at both 4 and
6 week time points [Fig. 1B; E12 N.Acc vs E14 N.Acc at 4 and 6 week.,
both p b 0.05]. Thus, rotational bias post-graft was signiﬁcantly higher
than post-lesion in the E14 N.Acc [Fig. 1B; Lesion vs E14 N.Acc at 4
and 6 week., both p b 0.05], whereas the graft did not affect rotational
asymmetry in the E12 N.Acc group [Fig. 1B; Lesion vs E12 N.Acc at 4
and 6 week., both n.s.].Fig. 1. VM grafts affect drug-induced rotational bias in the dSTR (A) and N.Acc (B) groups. Mea
2.5 mg/kg metamphetamine in lesioned and grafted rats in the E12 and E14 groups. Data are
recovery of the lesion-induced behavioural deﬁcit in the dSTR graft group. There was a signiﬁ
post-graft, the classic over-compensatory response. (B) Animals in the E14 N.Acc graft grou
±SEM, signiﬁcance levels: * or †p b 0.05, *** or ###p b 0.001.3.2. Transplantation site does not inﬂuence total neuron yield in ventral
mesencephalic grafts
Examination of NeuN-stained sections revealed surviving grafts in
all transplantation sites with large numbers of neurons homogeneously
distributed within the grafts as depicted in Fig. 2A–D. On average, there
were over 40,000 NeuN-ir cells in each graft. Given that E14 VMs
contained almost 5 times more cells than E12 VMs at the time of trans-
plantation, the yield of NeuN-ir neuronsmight have been expected to be
different between the two donor age groups. However, as shown in Fig.
2E, the yield of grafted neurons was very similar in all groups and was
not affected by the donor age [F(1,59) = 0.51, n.s.] or the transplantation
site [F(3,59) = 0.45, n.s.].
3.3. Younger donor tissue and striatal environment enhance dopamine neu-
ron survival and integration of ventral mesencephalic grafts
At 6 weeks post-transplantation, VM graft survival and integration
into 6-OHDA lesioned rat brain was examined by staining for TH (Fig.
3). Extensive ablation of the host dopaminergic midbrain pathways
was evidenced by virtually no (consistently b5%) surviving TH-ir neu-
rons in the lesioned SNpc (the origin of the A9 dopamine neurons)
and a partial (≈35–50%) loss of TH-ir neurons in the VTA (the origin
of the A10 dopamine neurons; Fig. 3I). TH staining conﬁrmed surviving
dopamine-rich grafts in all transplantation sites, and graft-derived TH-ir
ﬁbres were observed innervating the host tissue in all groups (Fig. 3A–
H). Dopaminergic innervation arising from E12 VM grafts appeared
denser and more extensive in all cerebral targets compared to E14 VM
grafts although outgrowth was not quantiﬁed. As clearly visible in Fig.
3, in both donor age groups, grafts in the dSTR and N.Acc showed the
greatest level of innervation of the host tissue, with substantial ﬁbre
outgrowth also seen in the PFC. In the HPC, dopamine neurons survived
in abundance but exhibited only very sparse axonal growth and only
into the immediate vicinity of the transplant site. E14 grafts contained
most TH-ir neurons in the periphery of the graft and only a few in the
centre of the graft (Fig. 3E–H). E12 grafts displayed a more homoge-
neous distribution of cells and a high density of TH processes within
the graft (Fig. 3A–D).
Younger donor tissue resulted in signiﬁcantly more TH-ir cells with-
in the grafts in most locations [Fig. 4A; Donor Age, F(1,60) = 36.18,
p b 0.001]. E12 grafts produced a signiﬁcantly higher yield of TH-ir
cells than E14 transplants in the dSTR [p b 0.001], N.Acc [p b 0.05] andn (ipsilateral minus contralateral) rotation score over 90 min following an i.p. injection of
collapsed across the secondary graft factor. (A) Both donor age graft groups produced a
cant change from ipsilateral rotation observed post-lesion to a net contralateral rotation
p exhibited enhanced (*) ipsilateral rotational behaviour post-graft. Error bars indicate
Fig. 2. Transplantation site does not inﬂuence total neuron yield in VM grafts in the Parkinsonian brain. (A–D) Photomicrographs illustrating NeuN staining of E12 VM grafts in different
transplantation targets: (A) dSTR, (B) N.Acc, (C) PFC, and (D) HPC. There is a clear boundary between the graft and the surrounding host brain. Neurons are homogeneously distributed
within the graft and their density appears to be higher in the graft than in the surrounding brain tissue. (A′) Highmagniﬁcation image from (A), illustrating themorphology of theNeuN-ir
cells within the graft. (E) Quantiﬁcation of NeuN-ir cells at 6 weeks post-graft revealed no signiﬁcant differences between the donor age groups and transplantation site groups (n.s.).
Columns depict group means; error bars illustrate ±SEM. Scale: A–D, 500 μm; A′: 50 μm. Abbreviations: dorsal striatum (dSTR), nucleus accumbens (N.Acc), prefrontal cortex (PFC),
hippocampus (HPC).
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grafts in the dSTRwere themost populous in TH-ir cell numbers in com-
parison to grafts in any other location, whereas for the E14 donor age
group the largest grafts were in the N.Acc. Also, grafts in the HPC
contained unexpectedly high numbers of TH-ir cells, especially in the
E12 donor age group. However, only E12 grafts in the dSTR produced
a signiﬁcantly higher yield of dopamine neurons than in the PFC [Trans-
plantation Site, F(3,60) = 2.98, p b 0.05; E12 dSTR vs E12 PFC, p b 0.01,
although this might be an artefact as some of the very anterior sections
of the PFC containing the graft were lost during tissue acquisition].
Given that the total number of surviving neurons was not signiﬁ-
cantly different between the groups, we should expect a higher propor-
tion of TH-ir/NeuN-ir cells in the E12 donor age group than E14 group to
account for the signiﬁcantly higher dopamineneuron yield in E12grafts.
Indeed, E12 grafts were more enriched for dopamine neurons than E14
grafts in most transplantation sites [Fig. 4B; Donor Age, F(1,59) = 24.02,
p b 0.001]. In line with signiﬁcant differences in the number of TH-ir
neurons, grafts derived from E12 rat embryos yielded a higher percent-
age of TH-ir/NeuN-ir neurons than E14 grafts in the dSTR [p b 0.01],
N.Acc [p b 0.01] and the HPC [p b 0.05] but not the PFC.
Generally, E12 grafts were slightly but signiﬁcantly bigger in volume
than E14 grafts in all transplantation sites [Fig. 4C; Donor Age, F(1,60) =
4.12, p b 0.05], despite the smaller numbers of cells implanted, whereas
no signiﬁcant differenceswere found between individual groups in graft
volume. Despite the fact that brain tissue in each transplantation site is
different in cell composition and density it did not affect the growth of
grafts [Transplantation Site, F(3,60) = 0.06, n.s.; Donor Age × Transplan-
tation Site, F(3,60) = 0.22, n.s.]. Analysis of dopamine neuron densities
revealed that E12 grafts were signiﬁcantly denser than E14 grafts [Fig.
4D; Donor Age, F(1,60) = 14.30, p b 0.001]. TH-ir cell density was signif-
icantly higher in E12 grafts than E14 grafts in the dSTR [p b 0.01] andN.Acc [p b 0.05]. The density of TH-ir neurons in the grafts varied little
between transplantation sites [Transplantation Site, F(3,60) = 0.76, n.s.].
3.4. Transplantation site inﬂuences the phenotypic differentiation of dopa-
mine neurons in ventral mesencephalic grafts
Fluorescent double staining for Girk2/TH and Calbindin/TH enabled
visualisation of the Girk2-ir A9-like and Calbindin-ir A10-like dopamine
neurons in the grafts and assessment of the effects of differential pres-
ence of A9 and A10 innervation targets in the transplantation sites on
the phenotypic differentiation of transplanted dopamine progenitors
(Fig. 5). Examination of labelled sections revealed presence of A9- and
A10-like dopamine neurons in all grafts where Girk2 and Calbindin
co-localised with TH in the cytoplasm of grafted neurons (Fig. 5A′,F′).
The majority of A9-like neurons were large and elongated in shape,
while A10-like neurons were smaller and more spherical. The yield of
A9-like dopamine neurons was predicted to be higher in the dSTR and
A10-like dopamine neuron yield was expected to be higher in the
N.Acc and PFC due to differential presence of A9 and A10 innervation
targets in these brain regions. Indeed, while Girk2-ir/TH-ir cells were
abundant in grafts in the dSTR and N.Acc in both donor age groups,
there were noticeably fewer Girk2/TH double labelled cells in grafts in
the PFC andHPC as depicted in Fig. 5A–D. Also, Girk2-ir ﬁbre density ap-
peared to be higher in the immediate vicinity of grafts in the dSTR as
compared to grafts in other transplantation sites. However, differences
in the populations of Calbindin/TH double labelled cells between trans-
plantation sites were less prominent (Fig. 5E–H).
There was a highly signiﬁcant difference between A9- and A10-like
dopamine neuron populations in the grafts [within-subject factor –
Staining, F(1,60) = 111.48, p b 0.001] inﬂuenced by both the host envi-
ronment [Transplantation Site, F(3,60) = 14.19, p b 0.001] and the VM
Fig. 3. Immunohistochemical analysis of dopamine neuron survival in VMgrafts in a ratmodel of PD. Photomicrographs of TH staining in E12 VMgrafts in the dSTR (A), N.Acc (B), PFC (C),
and HPC (D), and E14 VMgrafts in the same cerebral targets (E, F, G, and H, respectively) at 6 weeks post-transplantation illustrating abundant dopamine neuron survival and integration
into the host brain. (I) Photomicrograph of TH staining in a coronal section through 6-OHDA lesioned midbrain demonstrating extensive ablation of the host dopaminergic midbrain
pathways. (J) High magniﬁcation image illustrating the morphology of TH-ir neurons within the transplant and graft-derived dopaminergic axons extended into the surrounding
tissue. Grafts contained larger elongated TH-ir neurons suggestive of an A9-like phenotype (black arrow head) as well as smaller spherical neurons indicative of A10-like phenotype
(grey arrow head). Scale bars: 500 μm (A–I) and 20 μm (J). Abbreviations: dorsal striatum (dSTR), nucleus accumbens (N.Acc), prefrontal cortex (PFC), hippocampus (HPC).
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Age, F(3,60)= 4.48, p b 0.01]. In comparison to E14 grafts, E12 grafts pro-
duced a higher yield of both types of dopamine neurons in the dSTR
[p b 0.001] and N.Acc [p b 0.05] and a higher yield of A10-like neuronsin the HPC [p b 0.05]. This effect of the donor age group was not unex-
pected since E12 grafts yielded a signiﬁcantly higher number of TH-ir
cells than E14 grafts in all transplantation sites apart from the PFC. The
number of Girk2-ir/TH-ir cells was signiﬁcantly higher than Calbindin-
Fig. 4. Donor tissue age and transplantation site inﬂuence the number and density of TH-ir neurons in 6-week-old VM grafts in a rat model of PD. Data portray the total number of TH-ir
neurons (A) and the percentage of TH-ir/NeuN-ir cells (B) in the grafts, graft volumes (C) and the density of TH-ir neurons in the grafts (D). Columns depict group means; error bars
illustrate ±SEM; signiﬁcance levels: *p b 0.05, ** or ‡‡p b 0.01, ***p b 0.001. Abbreviations: dorsal striatum (dSTR), nucleus accumbens (N.Acc), prefrontal cortex (PFC), hippocampus
(HPC).
14 M. Fjodorova et al. / Experimental Neurology 291 (2017) 8–19ir/TH-ir cells in grafts in the dSTR [p b 0.001] and in theN.Acc [p b 0.001]
in both donor age groups and lower in the HPC in E12 grafts [p b 0.05].
Most importantly, E12 VM grafts produced the highest yield of A9-like
neurons in the dSTR than anywhere else [Fig. 5I; p b 0.001], with the
yield in grafts in N.Acc coming second and being signiﬁcantly higher
than that found in grafts in the PFC [Fig. 5I; p b 0.05] and HPC [Fig. 5I;
p b 0.001]. In the E14 donor age group, grafts in the dSTR and N.Acc
contained a comparable number of A9-like neurons that was higher
than that in grafts in the PFC and HPC [Fig. 5I; both p b 0.05]. The yield
of A10-like dopamine neurons in E14 grafts in N.Acc was higher than
in other brain regions but this did not reach statistical signiﬁcance
[Fig. 5J; simple effect of Transplantation Site for E14 group, F(3,60) =
0.85, n.s.]. In the E12donor age group [Fig. 5J; simple effect of Transplan-
tation Site for E12 group, F(3,60)=3.5, p b 0.05], only thenumber of A10-
like neurons in grafts in the dSTR was signiﬁcantly higher than in grafts
in the PFC [p b 0.05].
In order to account for the difference in TH-ir cell numbers between
two donor age groups, the yield of TH-ir neurons that were double-la-
belled with Girk2 and with Calbindin was calculated as a percentage
of overall number of dopamine neurons. The percentages of Girk2-ir/
TH-ir and Calbindin-ir/TH-ir cells in the dSTR and N.Acc added up to
105%, conﬁrming an overlap in Girk2 and Calbindin stained cells. Due
to limited availability of tissue and technical challenges, TH, Girk2 and
Calbindin triple-staining was not undertaken. However, we were able
to estimate an overlap of 11–17% in Girk2 and Calbindin staining in
grafted rat VMbydouble IHC in pilot experiments (Fjodorova, 2013). In-
terestingly, the sum of percentages of A9- and A10-like dopamine neu-
rons was 78% and 69% in grafts in the PFC and HPC, respectively,
indicating that almost a third of TH-ir neurons failed to co-express
Girk2 or Calbindin. The inﬂuence of A9 but not A10 dopaminergic tar-
gets in the transplantation site on the differentiation of grafted dopa-
mine progenitors persisted after accounting for differential survival of
E12 and E14 VM-derived grafts (Fig. 5K,L). Indeed, there was a highly
signiﬁcant difference between the percentages of A9- and A10-like neu-
rons in the grafts [within-subject factor – Staining, F(1,60) = 268.87,
p b 0.001] inﬂuenced only by the host environment and not the donorage group [Transplantation Site, F(3,60) = 91.81, p b 0.001; Donor Age,
F(1,60) = 1.14, n.s.; Transplantation Site × Donor Age, F(3,60) = 1.82,
n.s.]. The gain in the Girk2-ir/TH-ir and Calbindin-ir/TH-ir cell yields in
the E12 donor age group did not outweigh the general increase in the
number of TH-ir neurons between the two donor age groups. Signiﬁcant
differences between the percentages of Girk2-ir/TH-ir and Calbindin-ir/
TH-ir neurons (Fig. 5K,L) corresponded to signiﬁcant differences be-
tween the numbers of A9- and A10-like neurons in different graft
groups (Fig. 5I,J). A higher percentage of Girk2-ir/TH-ir cells was ob-
served in grafts in the dSTR than N.Acc and it continued to decrease in
grafts in the PFC and HPC (Fig. 5K). Thus, although the total number of
TH-ir neurons was affected by the environment, the decrease in
Girk2-ir/TH-ir cell numbers outweighed the general decrease. There
was a small increase in the percentage of Calbindin-ir/TH-ir cells in
grafts in the N.Acc as compared to grafts in other transplantation sites
in both donor age groups (Fig. 5L). However, even though there was a
main effect of the transplantation site on the percentage of Calbindin-
ir/TH-ir cells [Transplantation Site, F(3,60)= 4.68, p b 0.01] no signiﬁcant
differences between individual groups were found.
3.5. Transplantation site inﬂuences distribution of A9- and A10-like dopa-
mine neurons within ventral mesencephalic grafts
Graftmorphologywas inspected to determine thedistribution of do-
pamine neurons in the graft, with particular reference to their position
either in the periphery or in the central core of the graft. Analysis
showed that the majority of TH-ir neurons in the periphery were of
the A9-like phenotype in all grafts apart from grafts in HPC, while
fewer TH-ir neurons co-expressed Girk2 than Calbindin in the centre
of the grafts in most transplantation sites (Fig. 6). Girk2-ir/TH-ir neu-
rons were found predominantly in the periphery of grafts rather than
in the core while Calbindin-ir/TH-ir neurons were distributedmore ho-
mogeneously within the graft. The populations of cells in the periphery
were generally very different from those in the core [within-subject fac-
tor – Location, F(1,60) = 47.29, p b 0.001]. The A9-like dopamine cells
were affected more than the A10-like neurons by the location within
Fig. 5. Transplantation site inﬂuences A9-like dopamine neuron speciﬁcation in VM grafts. Coronal sections through E12 VM grafts illustrating TH-ir (green) neurons co-expressing Girk2
(red: A–D) or Calbindin (red: E–H) in grafts in the dSTR (A, E), N.Acc (B, F), PFC (C, G) and HPC (D, H). Note the increase in the Girk2-ir/TH-ir neuron population in grafts in the dSTR
compared to other grafts. (A′ and F′) High magniﬁcation images from (A and F), illustrating the co-localisation of Girk2 (A′) and Calbindin (F′) with TH and morphology of double
labelled neurons within the transplant. (I) Total number of Girk2-ir/TH-ir neurons and (J) Calbindin-ir/TH-ir neurons within the grafts at each donor age and transplantation site. (K)
Quantiﬁcation of the proportion of Girk2-ir/TH-ir neurons and (L) Calbindin-ir/TH-ir neurons out of total TH-ir neurons within the grafts. The presence of targeted midbrain
innervation of the transplantation site signiﬁcantly increased the number and proportion of A9-like neurons in the grafts. Scale bars: 100 μm (A–H) and 25 μm (A′ and F′). Columns
depict group means; error bars illustrate ±SEM; signiﬁcance levels: *p b 0.05, ***p b 0.001. Abbreviations: dorsal striatum (dSTR), nucleus accumbens (N.Acc), prefrontal cortex (PFC),
hippocampus (HPC).
15M. Fjodorova et al. / Experimental Neurology 291 (2017) 8–19
Fig. 6. Transplantation site inﬂuences distribution of A9- and A10-like dopamine neurons within VM grafts. Percentages of Girk2-ir/TH-ir and Calbindin-ir/TH-ir neurons in the periphery
and in the centre of E12 (A) and E14 grafts (B) at 6weeks post-transplantation. Note the decrease in the percentage of Girk2-ir/TH-ir neurons in the periphery of grafts inHPC compared to
grafts in other brain regions. The presence of A10 dopamine innervation of the N.Acc signiﬁcantly increased the percentage of A10-like neurons in the periphery of the graft compared to
the graft core in E14 group. Columns depict group means; error bars illustrate ±SEM; signiﬁcance levels: *p b 0.05, **p b 0.01, ***p b 0.001 and accordingly for other symbols; different
symbols are used to depict signiﬁcant differences between distinct groups as follows: *centre vs periphery for Girk2/TH %, #centre vs periphery for Calbindin/TH % [special case (#)
p b 0.1], †differences between Girk2/TH % and Calbindin/TH %, ‡differences between transplantation sites. Abbreviations: centre (C), periphery (P), dorsal striatum (dSTR), nucleus
accumbens (N.Acc), prefrontal cortex (PFC), hippocampus (HPC).
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p b 0.001; A10-like – n.s.]. Transplantation site also had an effect on
the distribution of dopamine neuron populations within the grafts
[Transplantation Site, F(3,60) = 3.44, p b 0.05] while VM age did not
[Donor Age, F(1,60) = 2.67, n.s.]. In both donor age groups, A9-like and
A10-like dopamine neurons were found mostly in the periphery of
grafts in N.Acc but in grafts in the dSTR this was true for A9-like neurons
only. There was a signiﬁcantly higher percentage of A10-like neurons in
the periphery than in the centre in grafts in N.Acc in E14 donor age
group [Fig. 6B; p b 0.05] whereas this approached but did not reach sta-
tistical signiﬁcance in E12 grafts [Fig. 6A; p b 0.1, n.s.]. Interestingly, per-
centages of Girk2-ir/TH-ir and Calbindin-ir/TH-ir cells in the periphery
of grafts added up to 90–100% in all groups apart from the HPC group.
There were≈50% of TH-ir cells in the centre of the graft in all groups
that did not co-express neither Girk2 nor Calbindin suggesting that
they most likely silenced their A9- and A10-like phenotypes.
The percentage of A9-like dopamine neurons in the periphery of
grafts was signiﬁcantly lower in grafts in the HPC than in the dSTR
[p b 0.01] and N.Acc [p b 0.01] in the E12 donor age group (Fig. 6A). In
E14 grafts, the percentage of Girk2-ir/TH-ir cells was signiﬁcantly
lower in the periphery of grafts in the PFC [p b 0.05] and HPC
[p b 0.01] than in the dSTR (Fig. 6B). There was a higher percentage of
Calbindin-ir/TH-ir neurons in the periphery of E12 grafts in the N.Acc
than in other transplantation sites but the differencewas not signiﬁcant.
Similarly, a higher percentage of A10-like dopamine neuronswas found
in the periphery of E14 grafts in N.Acc and PFC than in the dSTR or HPC
but the differences failed to reach statistical signiﬁcance.
4. Discussion
Improvement of functional efﬁcacy of the cell replacement therapy
for PD is still a major challenge that needs to be overcome. It is of para-
mount importance to understand the underlyingmechanisms that lead
to superior survival and integration of transplanted dopamine neurons.
Here we describe the importance of two critical factors, the presence of
A9/A10 dopamine innervation targets in the transplantation site and
the age/developmental stage of the donor tissue, in improving the
yield of functionally important A9-like dopamine neuron component
in rat VM grafts in a 6-OHDA lesion model of PD.
Several previous studies have highlighted the impact of donor age
on the cell therapy outcomes, reporting that grafting of younger
mouse and rat VM cells produces transplants with an enhanced dopa-
mine neuron yield and a greater proportion of A9-like dopamineneurons, as a result of increased progenitor proliferation and survival
and the presence of meningeal cells in tissue preparation at the time
of grafting (Bye et al., 2012; Somaa et al., 2015; Thompson et al., 2005;
Torres et al., 2008, 2007). Also, grafting of VMs into both dSTR and
N.Acc and re-innervation of the entire host striatum and the overlying
cerebral cortex has been described in detail in the past (Nikkhah et al.,
1994a, 1994b). However, the extent to which commitment of VM pro-
genitors at different stages in development to a speciﬁc dopamine neu-
ron phenotype can be inﬂuenced by the host environment surrounding
the graft has not previously been resolved.
The degree of innervation, patterning of regenerating axons and
sprouting of appropriate transplanted neurons into the target have all
been shown to be inﬂuenced by the host environment in studies in
the dSTR (Thompson et al., 2005), HPC (Björklund and Stenevi, 1981)
and sympathetic ganglia (Olson and Malmfors, 1970). This neuron-tar-
get interaction has been investigated and previous research has demon-
strated thatwhen transplanted in the vicinity of the dopamine-depleted
dSTR, e.g. into the adjacent cortex or ventricle, grafts derived from
human foetal VM tissue exhibited a target speciﬁc TH-irﬁbre outgrowth
(Stromberg et al., 1992). Also, dopamine neurons from the VM after
transplantation to the HPC ramiﬁed extensively in the denervated
perforant path zone but showed no tendency to grow into the normal
terminal zones of the noradrenergic afferents (Björklund et al., 1976).
Signiﬁcant differences in the A9- and A10-like dopamine neuron popu-
lations within striatal grafts observed in mouse and patient studies
(Mendez et al., 2005; Thompson et al., 2005) suggest that the host stri-
atum may preferentially inﬂuence the development and/or survival of
A9-like neurons.We therefore sought perform a systematic comparison
and examine the effect that the A9 and/or A10 dopaminergic target sta-
tus of the transplantation site may have on midbrain dopamine neuron
differentiation and survival in younger (E12) and conventional (E14)
VM grafts.
Within the present study each animal received two VM grafts, the
ﬁrst transplant into either dSTR or N.Acc and the second into either
PFC or HPC. Grafts in either the PFC or HPC did not interfere with
drug-induced rotational response provided by grafts in either dSTR or
N.Acc. The behavioural analysis of drug-induced rotation test revealed
a signiﬁcant recovery of rotational bias in rats grafted with VM tissue
into the dSTR in both donor age groups (Fig. 1A). This is in linewith pre-
vious observations of rat dopaminergic grafts providing sufﬁcient dopa-
mine supply to the dSTR to counteract severe rotational deﬁcits induced
by unilateral nigrostriatal pathway loss (Grealish et al., 2010; Torres et
al., 2008). Conversely, grafts in the N.Acc exacerbated the rotational
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pamine released by the graft had a net excitatory effect on N.Acc neu-
rons (Fig. 1B), compatible with the dual process model of rotation ﬁrst
proposed by Kelly and Moore (1976). Indeed, dopamine has been
shown to excite N.Acc neurons by preferentially inhibitingGABA release
during sustained stimulation in rat brain slices and inactivating dopa-
mine neurons reduces excitation of N.Acc neurons in rats (Hjelmstad,
2004; Yun et al., 2004). However, grafts in the E12 N.Acc group had no
effect on the rotational bias in response to amphetamine most likely
due to a higher degree of graft-derived innervation in the E12 group
and dopamine ﬁbres reaching the adjacent dSTR and modulating dopa-
mine release in N.Acc (Fig. 3B,F). Taken together these ﬁndings conﬁrm
that dopaminergic grafts survived and functionally integrated into the
host tissue providing regulated dopamine release in a physiological
manner.
The histological ﬁndings, including the total numbers of surviving
transplanted NeuN-ir neurons (Fig. 2E) and TH-ir neurons (Fig. 4A),
showed that the transplantation site had little inﬂuence on the overall
survival of VM grafts in either donor age group. As previously, the use
of younger donor age tissue was seen to be beneﬁcial to dopaminergic
neuron survival. When compared with 35,000 dopamine neurons in
the healthy adult rat VM (German and Manaye, 1993), current TH-ir
neuron yield in grafts in the E12 group, derived from implantation of
1/2 VM, represents up to 28% of the expected adult complement, a
much better result than conventional E14 grafts, which were able to
achieve only 12%. Of relevance, a recent study by Torres et al. (2007) re-
ported survival rates of dopamine neurons of over 35% when using
younger (E12) embryos. A similar impact of the donor agewas observed
inmouse VM grafts where DA neuron yield was 2.6-fold higher in grafts
derived from the E10 VM tissue as compared to the E12 VM tissue (Bye
et al., 2012). In another study, multiple rat E12 VM-derived intrastriatal
grafts produced an even higher yield of DA neurons (75% survival rate)
and innervated a greater volume of the dSTR (Torres et al., 2008). Sim-
ilarly, in the current experiment, dopaminergic innervation arising from
E12 VM grafts appeared denser and more extensive in all cerebral tar-
gets compared to E14 VM grafts (Fig. 3). Additionally, E12 grafts were
bigger and displayed higher density of TH-ir neurons than E14 grafts
in most locations (Fig. 4C,D). Thus, the increase in the total number of
TH-ir cells in grafts derived from younger donor tissues can be attribut-
ed to a denser distribution of dopamine neurons within the graft which
is accompanied by a slight increase in the graft volume.
As in the adult midbrain, VM grafts in this study contained two
recognisable classes of dopamine neurons: large elongated Girk2-ir
A9-like dopamine neurons of SNpc and smaller round Calbindin-ir
A10-like dopamine neurons of the VTA (Fig. 5). We acknowledge that
there is a 10–25% overlap in Girk2 and Calbindin expression inmidbrain
dopaminergic neurons (Bye et al., 2012; Grealish et al., 2010; Reyes et
al., 2012). However, these twomarkers together with cellular morphol-
ogy are currently the best two tools available to distinguish between
A9- and A10-like neurons in the grafts. Interestingly, we observed
both A9- and A10-like dopamine neurons in abundance in grafts in all
transplantation sites. Most importantly, the yield of A9-like neurons
followed a pattern with the highest number of Girk2-ir/TH-ir cells
found in grafts in the dSTR, which contains targets of A9 innervation
from the SNpc, followed by a progressive decrease of this neuron popu-
lation in E12 grafts in the N.Acc, PFC and HPC in the absence of the A9
dopamine innervation targets (Fig. 5I,K). E14 grafts in the dSTR and
N.Acc yielded similar numbers of the Girk2-ir/TH-ir cells indicating
that the differentiation/maturation of developmentally older dopamine
cells was less affected by the presence of environmental cues compared
to younger midbrain progenitors. Interestingly, it has been reported
that responsiveness to cues to direct phenotypic differentiation is
downregulated in older neurons (Van den Heuvel and Pasterkamp,
2008), which is the case observed in the present study. Nevertheless,
in the absence of A9 targets for innervation, E14 grafts in the PFC and
HPC produced signiﬁcantly lower numbers of A9-like neurons thangrafts in the dSTR and N.Acc. The environment rich in A10 innervation
targets in the N.Acc and PFC did not promote a signiﬁcant increase in
the Calbindin-ir/TH-ir neuron population compared to grafts in the
dSTR or HPC (Fig. 5J,L). Although the trend for changes in the population
of A10-like neurons went in the hypothesised direction for E14 VM
grafts, it did not reach statistical signiﬁcance. These observations are
in agreementwith a recent study that utilisedmouse-derived VM grafts
to investigate environmental cues provided by meningeal cells in the
developing midbrain and reported that older VM tissue as well as
A10-like neuron population were less affected (Somaa et al., 2015).
Consistent with previous reports, A9-like neurons were predomi-
nantly located in the periphery of grafts while A10-like neurons were
more homogeneously distributed within the graft (Mendez et al.,
2005, 2008; Thompson et al., 2005). The effect of the environment on
two dopamine neuron subtypes was more apparent in the periphery
of grafts rather than in the centre probably because neurons there
were more exposed to the surrounding cues, or because neurons in
the core were unable to extend axons in to the target area. Indeed,
around half of TH-ir neurons in the core of the grafts failed to co-express
either Girk2 or Calbindin and acquire a mature dopamine neuron phe-
notype, a phenomenon also observed in hVM grafts in PD patients
(Mendez et al., 2005, 2008). Most interestingly, striatal environment
was found to positively inﬂuence the yield of A9-like neurons in the pe-
riphery of grafts as compared to transplants in the PFC and HPC in both
donor age groups (Fig. 6). Without the necessary environmental cues
considerably fewer dopamine precursor cells matured into functional
A9-like neurons in the periphery of grafts implanted in the PFC and
HPC. Furthermore, grafts in the N.Acc contained slightly more A10-like
neurons in the periphery than grafts in other locations, but the differ-
ences were not signiﬁcant. Nevertheless, Calbindin-ir/TH-ir neurons
were found predominantly in the periphery of grafts in N.Acc rather
than in the centre, in both donor age groups, indicating that environ-
mental cues in the N.Acc might have inﬂuenced differentiation and/or
survival of A10-like dopamine progenitors or attracted their migration
to the periphery of the graft.
The absence of a greater effect of the transplantation site on the A10-
like neuron population in the grafts could be attributed, at least in part,
to the fact that a unilateral 6-OHDA lesion of the medial forebrain bun-
dle causes only a partial loss of dopamine neurons in the VTA and sub-
sequently achieves only a partial denervation of the N.Acc and PFC.
Indeed, previous studies have suggested that although dopamine grafts
survive equallywell both in the intact and lesioned striatal environment
(Dunnett et al., 1988; Schmidt et al., 1981), integration of the grafts in
adult recipients was reportedly poor unless the host systems were suf-
ﬁciently denervated. Taken together, the present results suggest that
the level of dopamine depletion in either A9 (dSTR) or A10 (N.Acc)
input nuclei in the basal ganglia may inﬂuence the preferential yield
of dopamine neuron phenotypes in the grafts.
A furthermajor determinant of a successful cell therapy is to achieve
adequate innervation of target tissue by the graft and restoration of do-
pamine supply. Irrespective of the dopamine neuron yield in a trans-
plant, failure to repair functional connections in the dSTR does not
improve motor function (Fricker-Gates and Dunnett, 2002). Meningeal
cells overlying the VM have been recently implicated not only in supe-
rior dopamine neuron yield in the graft but, most importantly, also in
an increased innervation of the host brain (Somaa et al., 2015). Those
authors demonstrated that an increase in innervation density is en-
hanced by stromal derived factor-1 (SDF1) secreted by meningeal
cells in the grafts. Current and previous observations of a greater ﬁbre
outgrowth achieved by grafts derived from younger VM tissue may be
similarly linked to the inﬂuence of meningeal cells as they were not re-
moved during graft preparations from rat E12 or mouse E10 VM tissue.
In contrast, meningeal cells were not included in older VM-derived
grafts (Bye et al., 2012; Torres et al., 2008). Previous research has dem-
onstrated that restoration of ﬁner motor skills requires a more global
restoration of the basal ganglia circuitry which can be achieved by
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(Dunnett et al., 1989; Mukhida et al., 2001, 2008). In clinical trials, PD
patients receive transplants primarily into the putamen and in some
cases also into either the caudate nucleus or SNpc.
Taken together, our current ﬁndings not only expand our under-
standing of grafted dopamine neuron differentiation and maturation
in the host brain, but also have signiﬁcant implications for further im-
proving dopamine cell therapy in PD in the future. Replacement of lost
neurons can be targeted to individual needs of each patient taking
into account speciﬁc patterns of neurodegeneration, thereby allowing
more precise restoration of the circuitry and neurotransmitter release.
In the present study, we demonstrated the ability of younger VM tissue
to use environmental cues in the transplantation site to guide terminal
A9- and A10-like phenotypic differentiation of dopamine neuron pro-
genitors in the graft. Thus, by transplanting younger human VM tissue
into different sites in the caudate nucleus, putamen and SNpc, it may
be possible to enrich grafts for a speciﬁc dopamine neuron population
to achieve a more extensive restoration of circuitry and improve the
quality of life for patients.
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